2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential
2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential